Kestra Medical Technologies Plans Q3 2025 Financial Results Release April 14

Kestra Medical Technologies Ltd. (KMTS) has announced that it will release its financial results for the third quarter of fiscal 2025 on April 14, 2025, with a conference call scheduled for 4:30 p.m. Eastern Time. This announcement aims to enhance transparency for investors, allowing them to prepare for the anticipated results. The company is focused on innovative solutions for cardiovascular disease, leveraging wearable medical device technology to improve patient outcomes. In addition to the earnings release, several financial analysts have recently initiated coverage of Kestra, with varying ratings and price targets, reflecting positive market sentiment towards the company's growth potential. Analysts have issued buy and overweight ratings alongside price targets ranging from $24 to $30, indicating confidence in Kestra's market positioning. The upcoming financial results are viewed as crucial for assessing the company's financial health and strategic direction.